MELD score includes A/E

Ans. is 'a' i.e., Sr. creatinine The Model for End-stage Liver Disese (MELD) is a prospectively developed and validated chronic liver disease severity scoring system that uses a patient's laboratory values for - Li Serum bilirubin Serum creatinine The international normalized ratio (INR) for prothrombin time to predict three month survival. Patients with cirrhosis, and increasing MELD score is associated with increasing severity of hepatic dysfunction and increased three-month moality risk. Given its accuracy in predicting sho-term survival among patients with cirrhosis, MELD was adopted by the United network for organ sharing (UNOS) in 2002 for prioritization or patients awaiting liver trasplantation in the United states. Pediatric end stage liver disease (PELD) Serum bilirubin INR Serum albumin Age Nutritional status